304 related articles for article (PubMed ID: 12023853)
21. Bleomycin-induced pulmonary fibrosis in the rat. Prevention with an inhibitor of collagen synthesis.
Kelley J; Newman RA; Evans JN
J Lab Clin Med; 1980 Dec; 96(6):954-64. PubMed ID: 6159435
[TBL] [Abstract][Full Text] [Related]
22. [Gene expression of messenger RNA coding for procollagen and tumour necrosis factor-alpha in lungs undergoing bleomycin-induced pulmonary fibrosis].
Cai H; Zheng P; Dai L
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Dec; 21(12):753-5. PubMed ID: 11480082
[TBL] [Abstract][Full Text] [Related]
23. Activation of somatostatin receptors attenuates pulmonary fibrosis.
Borie R; Fabre A; Prost F; Marchal-Somme J; Lebtahi R; Marchand-Adam S; Aubier M; Soler P; Crestani B
Thorax; 2008 Mar; 63(3):251-8. PubMed ID: 17951277
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory effect of emodin on bleomycin-induced pulmonary fibrosis in mice.
Chen XH; Sun RS; Hu JM; Mo ZY; Yang ZF; Jin GY; Guan WD; Zhong NS
Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):146-53. PubMed ID: 18785980
[TBL] [Abstract][Full Text] [Related]
25. Targeting protease activated receptor-1 with P1pal-12 limits bleomycin-induced pulmonary fibrosis.
Lin C; Duitman J; Daalhuisen J; Ten Brink M; von der Thüsen J; van der Poll T; Borensztajn K; Spek CA
Thorax; 2014 Feb; 69(2):152-60. PubMed ID: 24029744
[TBL] [Abstract][Full Text] [Related]
26. Role of the chemokine receptor CXCR2 in bleomycin-induced pulmonary inflammation and fibrosis.
Russo RC; Guabiraba R; Garcia CC; Barcelos LS; Roffê E; Souza AL; Amaral FA; Cisalpino D; Cassali GD; Doni A; Bertini R; Teixeira MM
Am J Respir Cell Mol Biol; 2009 Apr; 40(4):410-21. PubMed ID: 18836137
[TBL] [Abstract][Full Text] [Related]
27. Effect of granulocyte colony-stimulating factor on bleomycin-induced acute lung injury and pulmonary fibrosis.
Azoulay E; Herigault S; Levame M; Brochard L; Schlemmer B; Harf A; Delclaux C
Crit Care Med; 2003 May; 31(5):1442-8. PubMed ID: 12771616
[TBL] [Abstract][Full Text] [Related]
28. [Procoagulant activity of alveolar macrophages in bleomycin-induced lung fibrosis in rats].
Kobayashi N; Suko M; Sugiyama H; Dohi M; Okudaira H; Miyamoto T
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Jun; 28(6):867-74. PubMed ID: 1699018
[TBL] [Abstract][Full Text] [Related]
29. Effect of Feitai on bleomycin-induced pulmonary fibrosis in rats.
Gong LK; Li XH; Wang H; Zhang L; Chen FP; Cai Y; Qi XM; Liu LL; Liu YZ; Wu XF; Huang CG; Ren J
J Ethnopharmacol; 2005 Jan; 96(3):537-44. PubMed ID: 15619575
[TBL] [Abstract][Full Text] [Related]
30. Cysteinyl-leukotriene 1 receptor antagonist attenuates bleomycin-induced pulmonary fibrosis in mice.
Izumo T; Kondo M; Nagai A
Life Sci; 2007 Apr; 80(20):1882-6. PubMed ID: 17397875
[TBL] [Abstract][Full Text] [Related]
31. [Effects of Fuzheng Huayu recipe on MMP-2 activity and type IV collagen expression at fibrotic lung].
Tan SZ; Liu CH; Zhang W; Lu X; Ye WC; Cai ZZ; Liu P
Zhongguo Zhong Yao Za Zhi; 2007 May; 32(9):835-9. PubMed ID: 17639988
[TBL] [Abstract][Full Text] [Related]
32. Protease-activated receptor 1 knockout reduces experimentally induced liver fibrosis.
Rullier A; Gillibert-Duplantier J; Costet P; Cubel G; Haurie V; Petibois C; Taras D; Dugot-Senant N; Deleris G; Bioulac-Sage P; Rosenbaum J
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G226-35. PubMed ID: 17962354
[TBL] [Abstract][Full Text] [Related]
33. Factor Xa: at the crossroads between coagulation and signaling in physiology and disease.
Borensztajn K; Peppelenbosch MP; Spek CA
Trends Mol Med; 2008 Oct; 14(10):429-40. PubMed ID: 18774340
[TBL] [Abstract][Full Text] [Related]
34. Effects of Th2 pulmonary inflammation in mice with bleomycin-induced pulmonary fibrosis.
Hirata H; Arima M; Fukushima Y; Ishii Y; Tokuhisa T; Fukuda T
Respirology; 2008 Nov; 13(6):788-98. PubMed ID: 18811877
[TBL] [Abstract][Full Text] [Related]
35. ATLa, an aspirin-triggered lipoxin A4 synthetic analog, prevents the inflammatory and fibrotic effects of bleomycin-induced pulmonary fibrosis.
Martins V; Valença SS; Farias-Filho FA; Molinaro R; Simões RL; Ferreira TP; e Silva PM; Hogaboam CM; Kunkel SL; Fierro IM; Canetti C; Benjamim CF
J Immunol; 2009 May; 182(9):5374-81. PubMed ID: 19380784
[TBL] [Abstract][Full Text] [Related]
36. Protease-activated receptor (PAR)-2 is required for PAR-1 signalling in pulmonary fibrosis.
Lin C; von der Thüsen J; Daalhuisen J; ten Brink M; Crestani B; van der Poll T; Borensztajn K; Spek CA
J Cell Mol Med; 2015 Jun; 19(6):1346-56. PubMed ID: 25689283
[TBL] [Abstract][Full Text] [Related]
37. CD19 regulates the development of bleomycin-induced pulmonary fibrosis in a mouse model.
Komura K; Yanaba K; Horikawa M; Ogawa F; Fujimoto M; Tedder TF; Sato S
Arthritis Rheum; 2008 Nov; 58(11):3574-84. PubMed ID: 18975313
[TBL] [Abstract][Full Text] [Related]
38. Attenuation of bleomycin-induced lung fibrosis in rats by mesna.
El-Medany A; Hagar HH; Moursi M; At Muhammed R; El-Rakhawy FI; El-Medany G
Eur J Pharmacol; 2005 Feb; 509(1):61-70. PubMed ID: 15713430
[TBL] [Abstract][Full Text] [Related]
39. Double intratracheal instillation of keratinocyte growth factor prevents bleomycin-induced lung fibrosis in rats.
Sugahara K; Iyama K; Kuroda MJ; Sano K
J Pathol; 1998 Sep; 186(1):90-8. PubMed ID: 9875145
[TBL] [Abstract][Full Text] [Related]
40. Bleomycin-induced diffuse interstitial pulmonary fibrosis in baboons.
McCullough B; Collins JF; Johanson WG; Grover FL
J Clin Invest; 1978 Jan; 61(1):79-88. PubMed ID: 73549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]